ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective Trial

Clinical trial NCT06828861 · TERMINATED

Trial details

NCT number: NCT06828861
Sponsor: Aardvark Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Hyperphagia Prader-Willi Syndrome

Start date: 2024-12-20
Primary completion: 2026-05-07
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.